Harrington Discovery Institute

Showing   of 16 results

Jonathan Stamler

New Cause of Diabetes Discovered, Offering Potential Target for New Classes of Drugs to Treat the Disease

Researchers discovered a novel “carrier” enzyme (called SNO-CoA-assisted nitrosylase, or SCAN) that attaches nitric oxide to proteins, including the receptor for insulin action.

UH and Oxford Therapeutics launch event October 2023

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases

The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical...

AlveoGene logo for thumbnail

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.

Takeda Licenses LSU Health New Orleans Technology for Potential Rare Neurological Disorders

Harrington Discovery Institute Rare Disease Scholar Award Helps Moves Research Forward

Harrington Discovery Institute Announces 2023 Scholar-Innovator Award Recipients

Ten physician-scientists have been selected for drug development grant to advance discoveries into the clinic.

International Harrington Prize Jointly Awarded to Drs. Jean Bennett and Albert Maguire

2023 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Retinal Gene Therapy for Genetic Diseases.

Cleveland Researchers Reveal How Oxygen is Delivered to Tissues, Open Door to New Class of Drugs

Newfound clarity on the longstanding “medical mystery” may lead to new line of drugs for oxygen delivery disorders, including peripheral artery disease, sickle cell disease, heart failure, and others.

Oxford-Harrington Rare Disease Centre Hosts Virtual Event on Advancing Novel Therapies for Rare Diseases

Researchers discuss successes in their fields; rare disease family advocate shares story

Results are loading...